Accumulating CD57+CD3+ natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis

Liver International

Volumn 23, Issue 2, 2003, Pages 94-100

  Harada, Kenichi ^a   Isse, Kumiko ^a   Tsuneyama, Koichi ^a   Ohta, Hajime ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Tsuruga City Hospital   (Japan)

Author keywords

Extrahepatic T cells; Natural killer T cells; Primary biliary cirrhosis

Indexed keywords

CD3 ANTIGEN; CD57 ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; URSODEOXYCHOLIC ACID; COMPLEMENTARY DNA; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; BILE DUCT INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INTRAHEPATIC BILE DUCT; LIVER PARENCHYMA; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; MALE; MICROENVIRONMENT; NATURAL KILLER CELL; PHENOTYPE; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION; THYMUS; AGED; BILIARY CIRRHOSIS; COMPARATIVE STUDY; ELECTROPHORESIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; GENOME; IMMUNOLOGY; INTRAHEPATIC CHOLESTASIS; LIVER; METABOLISM; MIDDLE AGED; OBSTRUCTIVE JAUNDICE; PATHOLOGY; SCLEROSING CHOLANGITIS; STATISTICS; VIRUS HEPATITIS;

AGED; ANTIGENS, CD3; ANTIGENS, CD57; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHOLANGITIS, SCLEROSING; CHOLESTASIS, EXTRAHEPATIC; CHOLESTASIS, INTRAHEPATIC; DNA, COMPLEMENTARY; ELECTROPHORESIS; FEMALE; GENOME, HUMAN; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KILLER CELLS, NATURAL; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS;

EID: 0043288751     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2003.00807.x     Document Type: Article

References (38)

1. Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979; 76: 1326-32.
2. Kaplan M M. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-80.
3. Nakanuma Y, Ohta G. Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis. Hepatology 1983; 3: 423-7.
4. Gershwin M E, Mackay I R. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822-33.
5. Harada K, Van de Water J, Leung P S, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25: 791-6.
6. Shimoda S, Nakamura M, Ishibashi H, et al. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181: 1835-45.
7. Harada K, Tsuneyama K, Sudo Y, et al. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 2001; 33: 530-6.
8. Sato K, Ohtsuka K, Hasegawa K, et al. Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 1995; 182: 759-67.
9. + T cells which increase at tumor sites in patients with colorectal cancer. Clin Exp Immunol 1995; 102: 159-66.
10. Iiai T, Watanabi H, Seki S, et al. Ontogeny and development of extrathymic T cells in mouse liver. Immunology 1992; 77: 556-63.
11. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 2000; 174: 135-49.
12. Makino Y, Yamagata N, Sasho T, et al. Extrathymic development of V alpha 14-positive T cells. J Exp Med 1993; 177: 1399-408.
13. + T cells are present within a population of intermediate TCR cells. J Immunol 1995; 155: 2972-83.
14. + T cell populations. Int Immunol 1995; 7: 1157-61.
15. - T cells in mice and humans. J Exp Med 1994; 180: 1097-106.
16. Norris S, Doherty D G, Collins C, et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gamma-delta T cell receptor bearing cells. Hum Immunol 1999; 60: 20-31.
17. + T cells in patients with malignancy. Clin Exp Immunol 1994; 97: 522-7.
18. + NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2000; 164: 4458-64.
19. - T cells. J Exp Med 1997; 186: 109-20.
20. Funauchi M, Yu H, Sugiyama M, et al. Increased interleukin-4 production by NK T cells in systemic lupus erythematosus. Clin Immunol 1999; 92: 197-202.
21. + T cells in the peripheral blood of uveitis patients. Br J Ophthalmol 1999; 83: 1386-8.
22. + lymphocytes are numerous - implications for pathogenesis. Am J Dermatopathol 2000; 22: 7-16.
23. Wilson S B, Kent S C, Patton K T, et al. Extreme Th1 bias of invariant V alpha 24J alpha Q T cells in type-1 diabetes. Nature 1998; 391: 177-81.
24. Sumida T, Sakamoto A, Murata H, et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182: 1163-8.
25. Ludwig J, Dickson E R, McDonald G S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch Pathol Anat Histol 1978; 379: 103-12.
26. Harada K, Ozaki S, Gershwin M E, et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 1997; 26: 1399-405.
27. Abo T, Watanabe H, Iiai T, et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. Int Rev Immunol 1994; 11: 61-102.
28. Hammond K J, Pelikan S B, Crowe N Y, et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999; 29: 3768-81.
29. Wang Y, Goldschneider I, Foss D, et al. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a non-deletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 1997; 158: 2150-5.
30. +) T cells established from murine tumor-infiltrating lymphocytes. J Immunol 1997; 158: 4846-54.
31. + T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992; 79: 1746-53.
32. + lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 1993; 36: 608-12.
33. Watanabe T, Kawamura T, Kawamura H, et al. Intermediate TCR cells in mouse lung: their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease. J Immunol 1997; 158: 5805-14.
34. Yamazaki K, Ohsawa Y, Yoshie H. Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases. Am J Pathol 2001; 158: 1391-8.
35. Spada F M, Koezuka Y, Porcelli S A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998; 188: 1529-34.
36. Nieda M, Nicol A, Koezuka Y, et al. Activation of human V alpha 24 NKT cells by alpha-glycosylceramide in a CD1d-restricted and V alpha 24 TCR-mediated manner. Human Immunol 1999; 60: 10-9.
37. Jullien D, Stenger S, Ernst W A, et al. CD1 presentation of microbial nonpeptide antigens to T cells. J Clin Invest 1997; 99: 2071-4.
38. Tsuneyama K, Yasoshima M, Harada K, et al. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 1998; 28: 620-3.